GuidelinesOther guideline
Abbreviations
Abbreviations Definitions ART Antiretroviral treatment BCG Bacillus Calmette-Guérin CCMDD Central chronic medicine dispensing and distribution CHW Community health worker CLHIV Children living with HIV CXR Chest x-ray DHMIS District Health Management Information System DTG Dolutegravir DSD Differentiated service delivery DS-TB Drug-susceptible TB FDC Fixed-dose combinations HIV Human immunodefici
| Abbreviations | Definitions |
| ART | Antiretroviral treatment |
| BCG | Bacillus Calmette-Guérin |
| CCMDD | Central chronic medicine dispensing and distribution |
| CHW | Community health worker |
| CLHIV | Children living with HIV |
| CXR | Chest x-ray |
| DHMIS | District Health Management Information System |
| DTG | Dolutegravir |
| DSD | Differentiated service delivery |
| DS-TB | Drug-susceptible TB |
| FDC | Fixed-dose combinations |
| HIV | Human immunodeficiency virus |
| HLM | High level meeting |
| IGRA | Interferon-gamma release assay |
| IPT | Isoniazid preventive treatment |
| IRIS | Immune reconstitution inflammatory syndrome |
| LF-LAM | Lateral flow urine lipoarabinomannan assay |
| LFT | Liver function test |
| LTBI | Latent tuberculosis infection |
| MDR-TB | Multidrug-resistant TB |
| MMD | Multi-month dispensing |
| PEPFAR | President’s Emergency Plan for AIDS Relief |
| PLHIV | People living with HIV |
| PMTCT | Prevention of mother-to-child transmission |
| PHC | Primary healthcare |
| RPC | Repeated prescription collection |
| SDGs | Sustainable development goals |
| TB | Tuberculosis |
| TBTC | Tuberculosis Trials Consortium |
| TIER | Three interlinked electronic registers |
| TLD | Tenofovir / Lamivudine / Dolutegravir |
| TPT | TB preventive treatment |
| TST | Tuberculin skin test |
| UN | United Nations WHO World Health O |
| Xpert | GeneXpert MTB/RIF (Ultra, or latest recommended version) |
| 3HP | 3 months of weekly isoniazid plus rifapentine |
| 3RH | 3 months of daily rifampicin plus isoniazid |
| 6H | 6 months of daily isoniazid monotherapy |
| 12H | 12 months of daily isoniazid monotherapy |
National Guidelines on the Treatment of Tuberculosis Infection, February 2023
Abbreviations